Watch Ticker

Telix Pharmaceuticals Limited American Depositary Shares

Go to Telix Pharmaceuticals Limited American Depositary Shares Website

$12.26

0.00 (0.00%)

Live

Previous Close

$12.26

Day Range

$0 - $0

Previous Day Range

$12.1 - $12.37

Market Cap

$4.5 billion USD

Day Vol.

Previous Day Vol.

98547

Currency

USD

Primary Exchange

None

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Telix Pharmaceuticals Limited - Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

Telix Pharmaceuticals Limited announced its participation in the SNMMI 2025 Annual Meeting, featuring presentations on its theranostic programs and commercial products, including the ProstACT Global Phase 3 study and preclinical data on its TLX252 alpha therapy candidate.

Related tickers: TLX.

Read Full Article

N/A - Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share

The global radiopharmaceuticals market is projected to grow at a CAGR of 10.3% from 2024 to 2030, driven by the increasing prevalence of chronic diseases, advancements in imaging technology, and the transition towards personalized medicine. North America and Asia-Pacific are the key regional markets.

Related tickers: ATNM, DRTS, DRTSW, BAYRY, CAH, LLY, GEHC, LNTH, NVS, SMMNY, TLX.

Read Full Article

Trending Tickers

Please sign in to view